Hemab Therapeutics Holdings, Inc. (COAG): SCHEDULE 13G filed Aug 6, 2026

Name: Hemab Therapeutics Holdings, Inc. SCHEDULE 13G (0000315066-26-002021)
Creator: Hemab Therapeutics Holdings, Inc.
Published: 2026-08-06

Form type: SCHEDULE 13G
Filing date: Aug 6, 2026
Accession number: 0000315066-26-002021
Filer: Hemab Therapeutics Holdings, Inc. (CIK 2114044)